Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Loading...
Community
/
United States
/
Software
/
Cellebrite DI
CLBT
Cellebrite DI
Government Delays Will Limit Digital Forensics Efficacy But Boost Resilience
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
24 Aug 25
Updated
24 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$18.00
12.2% undervalued
intrinsic discount
24 Aug
US$15.80
1Y
-9.2%
7D
0%
Loading
1Y
-9.2%
7D
0%
Author's Valuation
US$18.0
12.2% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$18.0
12.2% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-317m
671m
2019
2021
2023
2025
2027
2028
Revenue US$670.6m
Earnings US$144.8m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
14.25%
Software revenue growth rate
1.47%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
10.66%
Calculation
US$144.76m
Earnings '28
x
50.39x
PE Ratio '28
=
US$7.29b
Market Cap '28
US$7.29b
Market Cap '28
/
299.49m
No. shares '28
=
US$24.36
Share Price '28
US$24.36
Share Price '28
Discounted to 2025 @ 10.67% p.a.
=
US$17.97
Fair Value '25
